James Mond
2020
In 2020, James Mond earned a total compensation of $1.2M as Executive Vice President, Chief Scientific Officer and Chief Medical Officer at ADMA Biologics, a 3% decrease compared to previous year.
Compensation breakdown
| Bonus | $233,200 |
|---|---|
| Option Awards | $167,544 |
| Salary | $440,000 |
| Stock Awards | $116,600 |
| Other | $238,004 |
| Total | $1,195,348 |
Mond received $440K in salary, accounting for 37% of the total pay in 2020.
Mond also received $233.2K in bonus, $167.5K in option awards, $116.6K in stock awards and $238K in other compensation.
Rankings
In 2020, James Mond's compensation ranked 7,852nd out of 13,090 executives tracked by ExecPay. In other words, Mond earned more than 40.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,852 out of 13,090 | 40th |
Division Manufacturing | 3,320 out of 5,621 | 41st |
Major group Chemicals And Allied Products | 1,346 out of 2,254 | 40th |
Industry group Drugs | 1,168 out of 1,954 | 40th |
Industry Biological Products, Except Diagnostic Substances | 275 out of 411 | 33rd |
Source: SEC filing on April 7, 2021.
Mond's colleagues
We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2020.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019